Lubiprostone
Composition
This formulation contain Lubiprostone as active agent
Indications
It is used to treat chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C) in adults.
Side effects
nausea, diarrhea, abdominal pain, bloating, flatulence, and headache
Precautions
should be used cautiously in patients with severe diarrhea or bowel obstructions
Contraindications
gastrointestinal obstruction, severe diarrhea, or hepatic impairment.
Dosage and administration
directed by a healthcare professional
Countries
Available Forms
Capsule
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai